BioMaxima S.A.

Warsaw Stock Exchange BMX.WA

BioMaxima S.A. Return on Capital Employed (ROCE) for the year ending December 31, 2023: 1.26%

BioMaxima S.A. Return on Capital Employed (ROCE) is 1.26% for the year ending December 31, 2023, a -97.81% change year over year. Return on capital employed assesses profitability against invested capital; higher ROCE signals efficient capital use.

BioMaxima S.A. Return on Capital Employed (ROCE) for the year ending December 31, 2022 was 57.28%, a 95.89% change year over year.
BioMaxima S.A. Return on Capital Employed (ROCE) for the year ending December 31, 2021 was 29.24%, a 19.90% change year over year.
BioMaxima S.A. Return on Capital Employed (ROCE) for the year ending December 31, 2020 was 24.39%, a 874.82% change year over year.
BioMaxima S.A. Return on Capital Employed (ROCE) for the year ending December 31, 2019 was 2.50%, a 404.47% change year over year.

Key data

Date	Return on Capital Employed (ROCE)	Interest Coverage Ratio	Debt to Equity Ratio	Return on Common Equity

Warsaw Stock Exchange: BMX.WA

BioMaxima S.A.

CEO	Mr. Lukasz Urban
IPO Date	July 21, 2010
Location	Poland
Headquarters	ul. VetterOw 5
Employees	115
Sector	Consumers Staples
Industries Personal Care Biotechnology Cleaning Supplies Fertilizers Medical Instruments Petrochemicals Pharmaceuticals Plastics

Description

BioMaxima S.A. manufactures and distributes reagents for in vitro diagnostics in Poland. Its primary products include diagnostic reagents and analyzers for clinical chemistry; rapid tests and readers for detecting infectious diseases, cancer markers, cardiac markers, and drugs of abuse; urine analysis systems; hematology analyzers and reagents; ionselective analyzers and reagents; reagents and immunological analyzers of cardiac markers; glucometers for professional use; and analyzers for gasometric tests and critical blood parameters tests. The company also provides surfaces and air controls; antibiotics discs and MIC strips; and chromogenic, dehydrated, and prepared culture media; and additives and supplements for media. It supplies its products to approximately 2,000 laboratories in Poland, as well as exports in the international markets. BioMaxima S.A. was founded in 2002 and is based in Lublin, Poland.

Key trends

Past 5 years